Arriva Pharmaceuticals' Series D Round

Arriva Pharmaceuticals raised a round of funding on May 21, 2002.

Arriva Pharmaceuticals, Inc. offers enzyme inhibitor replacement & therapy…

Articles about Arriva Pharmaceuticals' Series D Round: